Late presentation to HIV/AIDS testing, treatment or continued care: Clarifying the use of CD4 evaluation in the consensus definition

S. Maccarthy, David Bangsberg, G. Fink, M. Reich, S. Gruskin

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives: Late presentation to HIV/AIDS services compromises treatment outcomes and misses opportunities for biomedical and behavioural prevention. There has been significant heterogeneity in how the term 'late presentation' (LP) has been used in the literature. In 2011, a consensus definition was reached using CD4 counts to define and measure late presenters and, while it is useful for clinical care, the consensus definition has several important limitations that we discuss in this article. Methods: Using the spectrum of engagement in HIV care presented by Gardner and colleagues, this article highlights issues and opportunities associated with use of the consensus definition. Results: The consensus definition is limited by three principal factors: (1) the CD4 count threshold of 350cells/μL is being increasingly questioned as the biomedical justification grows for earlier initiation of treatment; (2) CD4 evaluations are conducted at multiple services providing HIV care; thus it remains unclear to which service the patient is presenting late; and (3) the limited availability of CD4 evaluation restricts its use in determining the prevalence of LP in many settings. Conclusions: The consensus definition is useful because it describes the level of disease progression and allows for consistent evaluation of the prevalence and determinants of LP. Suggestions are provided for improving the application of the consensus definition in future research.

Original languageEnglish (US)
Pages (from-to)130-134
Number of pages5
JournalHIV Medicine
Volume15
Issue number3
DOIs
StatePublished - Mar 2014
Externally publishedYes

Fingerprint

Acquired Immunodeficiency Syndrome
HIV
CD4 Lymphocyte Count
Disease Progression
Therapeutics

Keywords

  • CD4 evaluations
  • HIV/AIDS
  • Late presentation
  • Testing
  • Treatment

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Health Policy

Cite this

Late presentation to HIV/AIDS testing, treatment or continued care : Clarifying the use of CD4 evaluation in the consensus definition. / Maccarthy, S.; Bangsberg, David; Fink, G.; Reich, M.; Gruskin, S.

In: HIV Medicine, Vol. 15, No. 3, 03.2014, p. 130-134.

Research output: Contribution to journalArticle

@article{5a267ec7278f4114853510b1c9d6c7a4,
title = "Late presentation to HIV/AIDS testing, treatment or continued care: Clarifying the use of CD4 evaluation in the consensus definition",
abstract = "Objectives: Late presentation to HIV/AIDS services compromises treatment outcomes and misses opportunities for biomedical and behavioural prevention. There has been significant heterogeneity in how the term 'late presentation' (LP) has been used in the literature. In 2011, a consensus definition was reached using CD4 counts to define and measure late presenters and, while it is useful for clinical care, the consensus definition has several important limitations that we discuss in this article. Methods: Using the spectrum of engagement in HIV care presented by Gardner and colleagues, this article highlights issues and opportunities associated with use of the consensus definition. Results: The consensus definition is limited by three principal factors: (1) the CD4 count threshold of 350cells/μL is being increasingly questioned as the biomedical justification grows for earlier initiation of treatment; (2) CD4 evaluations are conducted at multiple services providing HIV care; thus it remains unclear to which service the patient is presenting late; and (3) the limited availability of CD4 evaluation restricts its use in determining the prevalence of LP in many settings. Conclusions: The consensus definition is useful because it describes the level of disease progression and allows for consistent evaluation of the prevalence and determinants of LP. Suggestions are provided for improving the application of the consensus definition in future research.",
keywords = "CD4 evaluations, HIV/AIDS, Late presentation, Testing, Treatment",
author = "S. Maccarthy and David Bangsberg and G. Fink and M. Reich and S. Gruskin",
year = "2014",
month = "3",
doi = "10.1111/hiv.12088",
language = "English (US)",
volume = "15",
pages = "130--134",
journal = "HIV Medicine",
issn = "1464-2662",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Late presentation to HIV/AIDS testing, treatment or continued care

T2 - Clarifying the use of CD4 evaluation in the consensus definition

AU - Maccarthy, S.

AU - Bangsberg, David

AU - Fink, G.

AU - Reich, M.

AU - Gruskin, S.

PY - 2014/3

Y1 - 2014/3

N2 - Objectives: Late presentation to HIV/AIDS services compromises treatment outcomes and misses opportunities for biomedical and behavioural prevention. There has been significant heterogeneity in how the term 'late presentation' (LP) has been used in the literature. In 2011, a consensus definition was reached using CD4 counts to define and measure late presenters and, while it is useful for clinical care, the consensus definition has several important limitations that we discuss in this article. Methods: Using the spectrum of engagement in HIV care presented by Gardner and colleagues, this article highlights issues and opportunities associated with use of the consensus definition. Results: The consensus definition is limited by three principal factors: (1) the CD4 count threshold of 350cells/μL is being increasingly questioned as the biomedical justification grows for earlier initiation of treatment; (2) CD4 evaluations are conducted at multiple services providing HIV care; thus it remains unclear to which service the patient is presenting late; and (3) the limited availability of CD4 evaluation restricts its use in determining the prevalence of LP in many settings. Conclusions: The consensus definition is useful because it describes the level of disease progression and allows for consistent evaluation of the prevalence and determinants of LP. Suggestions are provided for improving the application of the consensus definition in future research.

AB - Objectives: Late presentation to HIV/AIDS services compromises treatment outcomes and misses opportunities for biomedical and behavioural prevention. There has been significant heterogeneity in how the term 'late presentation' (LP) has been used in the literature. In 2011, a consensus definition was reached using CD4 counts to define and measure late presenters and, while it is useful for clinical care, the consensus definition has several important limitations that we discuss in this article. Methods: Using the spectrum of engagement in HIV care presented by Gardner and colleagues, this article highlights issues and opportunities associated with use of the consensus definition. Results: The consensus definition is limited by three principal factors: (1) the CD4 count threshold of 350cells/μL is being increasingly questioned as the biomedical justification grows for earlier initiation of treatment; (2) CD4 evaluations are conducted at multiple services providing HIV care; thus it remains unclear to which service the patient is presenting late; and (3) the limited availability of CD4 evaluation restricts its use in determining the prevalence of LP in many settings. Conclusions: The consensus definition is useful because it describes the level of disease progression and allows for consistent evaluation of the prevalence and determinants of LP. Suggestions are provided for improving the application of the consensus definition in future research.

KW - CD4 evaluations

KW - HIV/AIDS

KW - Late presentation

KW - Testing

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84893516821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893516821&partnerID=8YFLogxK

U2 - 10.1111/hiv.12088

DO - 10.1111/hiv.12088

M3 - Article

C2 - 24024559

AN - SCOPUS:84893516821

VL - 15

SP - 130

EP - 134

JO - HIV Medicine

JF - HIV Medicine

SN - 1464-2662

IS - 3

ER -